Global Substance Abuse and Addiction Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: Size, Share, Growth, Trends, and Global Industry Analysis By Type (Medication-Assisted Treatment (MAT), Behavioural Therapy and Counselling, Detoxification, Rehabilitation Programs (Inpatient & Outpatient), Support Groups), Substance type (Alcohol, Tobacco/Nicotine, Opioids, Cannabis, Stimulants (e.g., Cocaine, Methamphetamine), Prescription Drugs, Others), Application (Hospitals & Clinics, Rehabilitation Centres, Online Platforms, Community Health Centres), and Region 2020-2031

Substance Abuse and Addiction Treatment Market size was valued at US$ 13,336.2 million in 2024 andis projected to reach US$ 23,154.4 million by 2031 at a CAGR of 8.2% from 2025-2031. Moreover, the U.S. Substance Abuse and Addiction Treatment Market is projected to grow significantly at a CAGR of 8% over the forecast period. The market is witnessing steady growth driven by rising awareness, increased government funding, and the growing prevalence of drug and alcohol dependency worldwide. The integration of telehealth services and the adoption of evidence-based therapies are further transforming the treatment landscape.

The demand for addiction treatment is expected to increase due to mental health awareness, and a shift toward holistic recovery approaches. Market players are increasingly investing in personalized treatment programs, expanding access to care, and leveraging digital platforms to improve patient outcomes.

Facts and Figures

• Global Addiction Prevalence: Approximately 35 million people worldwide suffer from drug use disorders, with opioid addiction accounting for a significant portion of this number, contributing to the growing demand for specialized treatment programs.
• Treatment Utilization: Around 40%-60% of individuals who complete inpatient rehabilitation programs experience long-term recovery, highlighting the increasing efficacy and adoption of these treatment services.
• Telemedicine Growth: The use of telehealth in addiction treatment has grown by over 300% since 2020, driven by the COVID-19 pandemic and the subsequent rise in remote care and virtual therapy sessions.

Recent Developments

• In April 2025, the CDC reported a 25% decrease in U.S. drug overdose deaths and a 33% drop in synthetic opioid fatalities over the previous year. This progress is attributed to expanded public health initiatives and widespread naloxone distribution. However, recent federal policy changes, including significant funding cuts and layoffs in key health agencies, have raised concerns about potential setbacks in addiction treatment efforts.
• In January 2025, the New York state government proposed replacing the term "addict" with "person with a substance use disorder" in official communications. This initiative aims to reduce stigma and encourage individuals to seek treatment. The proposal is part of a broader $252 billion budget plan to combat the opioid epidemic, which includes allocating $1.25 billion for substance abuse treatment.

Substance Abuse And Addiction Treatment Market Segmentation

Based on the type:

• Medication-Assisted Treatment (MAT)
• Behavioural Therapy and Counselling
• Detoxification
• Rehabilitation Programs (Inpatient & Outpatient)
• Support Groups

The Medication-Assisted Treatment (MAT) segment is anticipated to lead the market due to its high effectiveness in managing substance use disorders, particularly opioid addiction. MAT combines FDA-approved medications like methadone, buprenorphine, or naltrexone with counselling and behavioural therapies, offering a comprehensive approach to recovery. This method has shown significant success in reducing cravings, preventing relapse, and improving treatment adherence. As the opioid crisis continues to impact millions globally, governments and healthcare organizations are increasingly supporting MAT through policy initiatives and funding. Its growing acceptance among medical professionals and patients’ alike positions MAT as the dominant driver within the market.

Based on the substance type:

• Alcohol
• Tobacco/Nicotine
• Opioids
• Cannabis
• Stimulants (e.g., Cocaine, Methamphetamine)
• Prescription Drugs
• Others

Among the substance types, Opioids are expected to be the leading driver in the market. The opioid crisis, particularly in regions like North America, has led to a surge in addiction rates, driving a significant demand for treatment solutions. Opioid addiction, involving substances like heroin and prescription painkillers (e.g., oxycodone), is highly addictive and often requires long-term management, including Medication-Assisted Treatment (MAT) and rehabilitation. The increasing number of opioid-related overdose deaths, along with heightened public awareness, has pushed governments and healthcare systems to prioritize opioid addiction treatment. With ongoing research into effective therapies and the expansion of MAT programs, opioids are anticipated to remain the dominant substance category in the market.

Based on the application:

• Hospitals & Clinics
• Rehabilitation Centres
• Online Platforms
• Community Health Centres

Among the application segments, Rehabilitation Centres are expected to lead the market. These centres, offering both inpatient and outpatient services, provide specialized care for individuals battling substance use disorders. The demand for rehabilitation centres is rising due to the increased number of people seeking structured treatment programs, including detoxification, behavioural therapies, and aftercare services. Rehabilitation centres offer a controlled environment that is essential for recovery, particularly for those with severe addiction issues.

Additionally, with more healthcare systems recognizing addiction as a treatable medical condition, rehabilitation centres continue to be a critical component in addressing the global substance abuse crisis. Their established reputation for providing comprehensive care and ongoing support solidifies their leading role in the market.